
ASGO Education
/X
Jun 14, 2025, 15:22
ASGO Journal Club Presents an Insightful Session: Chemotherapy Response Score No Longer Predicts Survival in BRCA Mutated Ovarian Cancer
ASGO Education shared a post on X:
“Dear all, The ASGO Journal Club presents an insightful session titled “Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy.” “
Read for further details.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 15, 2025, 02:23
Jun 14, 2025, 18:35
Jun 14, 2025, 17:40